Integrated single-cell transcriptome and TCR profiles of hepatocellular carcinoma highlight the convergence on interferon signaling during immunotherapy
Background Despite the success of immune checkpoint inhibitor (ICI)-based combination therapies in hepatocellular carcinoma (HCC), its effectiveness remains confined to a subset of patients. The development of reliable, predictive markers is important for accurate patient stratification and further...
Saved in:
| Main Authors: | Xiaobo Li, Chang Xu, Mingjie Zhang, Shengnan Guo, Dapeng Hao, Changqing Liu, Jing Ren, Guangyu Wang, Cheng Lyu, Tianhao Li, Huanhuan Xu, Zepeng Hou, Mingshuo Zhang, Dan Kong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/12/11/e010534.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TCR-based cellular immunotherapy for hepatocellular carcinoma: advances, challenges, and prospects
by: Wanting Zeng, et al.
Published: (2025-07-01) -
Neoepitope BTLAP267L-specific TCR-T cell immunotherapy unlocks precision treatment for hepatocellular carcinoma
by: Fang Liu, et al.
Published: (2025-04-01) -
Intratumoral convergence of the TCR repertoires of effector and Foxp3+ CD4+ T cells.
by: Michal Kuczma, et al.
Published: (2010-10-01) -
Exploiting TCR Repertoire Analysis to Select Therapeutic TCRs for Cancer Immunotherapy
by: Ursule M. Demaël, et al.
Published: (2025-08-01) -
TCR-Engineered, Customized, Antitumor T Cells for Cancer Immunotherapy: Advantages and Limitations
by: Arvind Chhabra
Published: (2011-01-01)